Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Ongoing Initiated Dec 30, 2025 (9 months ago)

Fluocinolone Acetonide Solution Topical Solution USP

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4

Affected NDC 51672-1365-04

Compare with the code on your package — it is the most precise check available.

Drug: Fluocinolone

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Fluocinolone Acetonide
NDC 51672-1365
.1 mg/mL Solution
Topical
Sun Pharmaceutical Industries, Inc. Rx
Recalling firm
Sun Pharmaceutical Industries INC
NDC code
51672-1365-4
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0256-2026 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm.

Other Fluocinolone recalls

See all
Class II · Moderate risk

Fluocinolone Acetonide Oil

Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol

Terminated Failed specification Glenmark Pharmaceuticals Inc., USA NDC 68462-185-56 D-0259-2024
Class II · Moderate risk

DermOtic Oil

Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.

Terminated Particulate / foreign matter Hill Dermaceuticals, Inc. NDC 68791-103-20 D-0637-2021
Class II · Moderate risk

Formula 82M

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1424-2020
Class II · Moderate risk

Formula 82F

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1423-2020

Other recalls by Sun Pharmaceutical Industries INC

All 2025 recalls
Class II · Moderate risk

Carbamazepine Tablets

CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing

Ongoing cGMP deviation Sun Pharmaceutical Industries INC NDC 51672-4005-3 D-0770-2026
Class II · Moderate risk

Perampanel CIII Tablets

Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.

Ongoing Labeling / mix-up Sun Pharmaceutical Industries INC NDC 51672-4206-6 D-0628-2026